APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Protein Expression and Purification

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Protein Expression and Purification Market Analysis and Forecast 2026-2032

Report ID 174227820216 April 2026242 pages

Choose your research edition.

Industry ResearchRecombinant Protein Expression and Purification Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Protein Expression and Purification Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Recombinant Protein Expression and Purification Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Protein Expression and Purification Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Recombinant Protein Expression and Purification Market Analysis and Forecast 2026-2032242 pages · $4,950 USD

Market perspective

The global Recombinant Protein Expression and Purification market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Recombinant Protein Expression and Purification is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Protein Expression and Purification is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Protein Expression and Purification is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Protein Expression and Purification is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Recombinant Protein Expression and Purification include Charles River, Biomatik, R&D Systems, Applied Biological Materials Inc. (abm), VectorBuilder, BiologicsCorp, Proteos, RayBiotech and Leinco Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Recombinant Protein Expression and Purification, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Protein Expression and Purification, also provides the revenue of main regions and countries. Of the upcoming market potential for Recombinant Protein Expression and Purification, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Protein Expression and Purification revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Protein Expression and Purification market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Protein Expression and Purification revenue, projected growth trends, production technology, application and end-user industry.

Recombinant Protein Expression and Purification Segment by Company

Charles River

Biomatik

R&D Systems

Applied Biological Materials Inc. (abm)

VectorBuilder

BiologicsCorp

Proteos

RayBiotech

Leinco Technologies

Kinexus Bioinformatics

InVivo BioTech Services GmbH

Expression Systems

Creative Biolabs

G&P Biosciences

Eurofins Discovery

Levprot Bioscience

eEnzyme

NorthX Biologics

Jubilant Biosys

GenScript

Boster Bio

Sino Biological

WuXi Biologic

CUSABIO TECHNOLOGY

OriGene Technologies

ProMab Biotechnologies

Creative BioMart

Thermo Fisher Scientific

Recombinant Protein Expression and Purification Segment by Type

Microbial Expression

Mammalian Cell Expression

Others

Recombinant Protein Expression and Purification Segment by Application

Pharmaceutical and Biopharmaceutical Company

Research Laboratory

Hospital

Other

Recombinant Protein Expression and Purification Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Protein Expression and Purification market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Protein Expression and Purification and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Protein Expression and Purification.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Recombinant Protein Expression and Purification in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Recombinant Protein Expression and Purification company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Protein Expression and Purification revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Protein Expression and Purification Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Microbial Expression Major Player Table 3. Mammalian Cell Expression Major Player Table 4. Others Major Player Table 5. Global Recombinant Protein Expression and Purification Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical and Biopharmaceutical Company Major Player Table 7. Research Laboratory Major Player Table 8. Hospital Major Player Table 9. Other Major Player Table 10. Recombinant Protein Expression and Purification Industry Trends Table 11. Recombinant Protein Expression and Purification Industry Drivers Table 12. Recombinant Protein Expression and Purification Industry Opportunities and Challenges Table 13. Recombinant Protein Expression and Purification Industry Restraints Table 14. Global Recombinant Protein Expression and Purification Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Recombinant Protein Expression and Purification Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Recombinant Protein Expression and Purification Market Share by Region (2021-2026) Table 17. Global Recombinant Protein Expression and Purification Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Recombinant Protein Expression and Purification Market Share by Region (2027-2032) Table 19. Global Recombinant Protein Expression and Purification Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Recombinant Protein Expression and Purification Revenue Market Share by Players (2021-2026) Table 21. Global Recombinant Protein Expression and Purification Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Recombinant Protein Expression and Purification Key Players Headquarters & Area Served Table 23. Global Recombinant Protein Expression and Purification Players, Product Type & Application Table 24. Global Recombinant Protein Expression and Purification Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Recombinant Protein Expression and Purification by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Recombinant Protein Expression and Purification Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Recombinant Protein Expression and Purification Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Recombinant Protein Expression and Purification Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Recombinant Protein Expression and Purification Revenue Market Share by Type (2021-2026) Table 31. Global Recombinant Protein Expression and Purification Revenue Market Share by Type (2027-2032) Table 32. Global Recombinant Protein Expression and Purification Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Recombinant Protein Expression and Purification Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Recombinant Protein Expression and Purification Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Recombinant Protein Expression and Purification Revenue Market Share by Application (2021-2026) Table 36. Global Recombinant Protein Expression and Purification Revenue Market Share by Application (2027-2032) Table 37. Charles River Company Information Table 38. Charles River Business Overview Table 39. Charles River Recombinant Protein Expression and Purification Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Charles River Recombinant Protein Expression and Purification Product Portfolio Table 41. Charles River Recent Development Table 42. Biomatik Company Information Table 43. Biomatik Business Overview Table 44. Biomatik Recombinant Protein Expression and Purification Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Biomatik Recombinant Protein Expression and Purification Product Portfolio Table 46. Biomatik Recent Development Table 47. R&D Systems Company Information Table 48. R&D Systems Business Overview Table 49. R&D Systems Recombinant Protein Expression and Purification Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. R&D Systems Recombinant Protein Expression and Purification Product Portfolio Table 51. R&D Systems Recent Development Table 52. Applied Biological Materials Inc. (abm) Company Information Table 53. Applied Biological Materials Inc. (abm) Business Overview Table 54. Applied Biological Materials Inc. (abm) Recombinant Protein Expression and Purification Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Applied Biological Materials Inc. (abm) Recombinant Protein Expression and Purification Product Portfolio Table 56. Applied Biological Materials Inc. (abm) Recent Development Table 57. VectorBuilder Company Information Table 58. VectorBuilder Business Overview Table 59. VectorBuilder Recombinant Protein Expression and Purification Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. VectorBuilder Recombinant Protein Expression and Purification Product Portfolio Table 61. VectorBuilder Recent Development Table 62. BiologicsCorp Company Information Table 63. BiologicsCorp Business Overview Table 64. BiologicsCorp Recombinant Protein Expression and Purification Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. BiologicsCorp Recombinant Protein Expression and Purification Product Portfolio Table 66. BiologicsCorp Recent Development Table 67. Proteos Company Information Table 68. Proteos Business Overview Table 69. Proteos Recombinant Protein Expression and Purification Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Proteos Recombinant Protein Expression and Purification Product Portfolio Table 71. Proteos Recent Development Table 72. RayBiotech Company Information Table 73. RayBiotech Business Overview Table 74. RayBiotech Recombinant Protein Expression and Purification Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. RayBiotech Recombinant Protein Expression and Purification Product Portfolio Table 76. RayBiotech Recent Development Table 77. Leinco Technologies Company Information Table 78. Leinco Technologies Business Overview Table 79. Leinco Technologies Recombinant Protein Expression and Purification Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Leinco Technologies Recombinant Protein Expression and Purification Product Portfolio Table 81. Leinco Technologies Recent Development Table 82. Kinexus Bioinformatics Company Information Table 83. Kinexus Bioinformatics Business Overview Table 84. Kinexus Bioinformatics Recombinant Protein Expression and Purification Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Kinexus Bioinformatics Recombinant Protein Expression and Purification Product Portfolio Table 86. Kinexus Bioinformatics Recent Development Table 87. InVivo BioTech Services GmbH Company Information Table 88. InVivo BioTech Services GmbH Business Overview Table 89. InVivo BioTech Services GmbH Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. InVivo BioTech Services GmbH Recombinant Protein Expression and Purification Product Portfolio Table 91. InVivo BioTech Services GmbH Recent Development Table 92. Expression Systems Company Information Table 93. Expression Systems Business Overview Table 94. Expression Systems Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Expression Systems Recombinant Protein Expression and Purification Product Portfolio Table 96. Expression Systems Recent Development Table 97. Creative Biolabs Company Information Table 98. Creative Biolabs Business Overview Table 99. Creative Biolabs Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Creative Biolabs Recombinant Protein Expression and Purification Product Portfolio Table 101. Creative Biolabs Recent Development Table 102. G&P Biosciences Company Information Table 103. G&P Biosciences Business Overview Table 104. G&P Biosciences Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. G&P Biosciences Recombinant Protein Expression and Purification Product Portfolio Table 106. G&P Biosciences Recent Development Table 107. Eurofins Discovery Company Information Table 108. Eurofins Discovery Business Overview Table 109. Eurofins Discovery Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Eurofins Discovery Recombinant Protein Expression and Purification Product Portfolio Table 111. Eurofins Discovery Recent Development Table 112. Levprot Bioscience Company Information Table 113. Levprot Bioscience Business Overview Table 114. Levprot Bioscience Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Levprot Bioscience Recombinant Protein Expression and Purification Product Portfolio Table 116. Levprot Bioscience Recent Development Table 117. eEnzyme Company Information Table 118. eEnzyme Business Overview Table 119. eEnzyme Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. eEnzyme Recombinant Protein Expression and Purification Product Portfolio Table 121. eEnzyme Recent Development Table 122. NorthX Biologics Company Information Table 123. NorthX Biologics Business Overview Table 124. NorthX Biologics Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. NorthX Biologics Recombinant Protein Expression and Purification Product Portfolio Table 126. NorthX Biologics Recent Development Table 127. Jubilant Biosys Company Information Table 128. Jubilant Biosys Business Overview Table 129. Jubilant Biosys Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Jubilant Biosys Recombinant Protein Expression and Purification Product Portfolio Table 131. Jubilant Biosys Recent Development Table 132. GenScript Company Information Table 133. GenScript Business Overview Table 134. GenScript Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. GenScript Recombinant Protein Expression and Purification Product Portfolio Table 136. GenScript Recent Development Table 137. Boster Bio Company Information Table 138. Boster Bio Business Overview Table 139. Boster Bio Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Boster Bio Recombinant Protein Expression and Purification Product Portfolio Table 141. Boster Bio Recent Development Table 142. Sino Biological Company Information Table 143. Sino Biological Business Overview Table 144. Sino Biological Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Sino Biological Recombinant Protein Expression and Purification Product Portfolio Table 146. Sino Biological Recent Development Table 147. WuXi Biologic Company Information Table 148. WuXi Biologic Business Overview Table 149. WuXi Biologic Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. WuXi Biologic Recombinant Protein Expression and Purification Product Portfolio Table 151. WuXi Biologic Recent Development Table 152. CUSABIO TECHNOLOGY Company Information Table 153. CUSABIO TECHNOLOGY Business Overview Table 154. CUSABIO TECHNOLOGY Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. CUSABIO TECHNOLOGY Recombinant Protein Expression and Purification Product Portfolio Table 156. CUSABIO TECHNOLOGY Recent Development Table 157. OriGene Technologies Company Information Table 158. OriGene Technologies Business Overview Table 159. OriGene Technologies Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. OriGene Technologies Recombinant Protein Expression and Purification Product Portfolio Table 161. OriGene Technologies Recent Development Table 162. ProMab Biotechnologies Company Information Table 163. ProMab Biotechnologies Business Overview Table 164. ProMab Biotechnologies Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. ProMab Biotechnologies Recombinant Protein Expression and Purification Product Portfolio Table 166. ProMab Biotechnologies Recent Development Table 167. Creative BioMart Company Information Table 168. Creative BioMart Business Overview Table 169. Creative BioMart Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Creative BioMart Recombinant Protein Expression and Purification Product Portfolio Table 171. Creative BioMart Recent Development Table 172. Thermo Fisher Scientific Company Information Table 173. Thermo Fisher Scientific Business Overview Table 174. Thermo Fisher Scientific Recombinant Protein Expression and Purification Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Thermo Fisher Scientific Recombinant Protein Expression and Purification Product Portfolio Table 176. Thermo Fisher Scientific Recent Development Table 177. North America Recombinant Protein Expression and Purification Revenue by Type (2021-2026) & (US$ Million) Table 178. North America Recombinant Protein Expression and Purification Revenue by Type (2027-2032) & (US$ Million) Table 179. North America Recombinant Protein Expression and Purification Revenue by Application (2021-2026) & (US$ Million) Table 180. North America Recombinant Protein Expression and Purification Revenue by Application (2027-2032) & (US$ Million) Table 181. North America Recombinant Protein Expression and Purification Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. North America Recombinant Protein Expression and Purification Revenue by Country (2021-2026) & (US$ Million) Table 183. North America Recombinant Protein Expression and Purification Revenue by Country (US$ Million) & (2027-2032) Table 184. Europe Recombinant Protein Expression and Purification Revenue by Type (2021-2026) & (US$ Million) Table 185. Europe Recombinant Protein Expression and Purification Revenue by Type (2027-2032) & (US$ Million) Table 186. Europe Recombinant Protein Expression and Purification Revenue by Application (2021-2026) & (US$ Million) Table 187. Europe Recombinant Protein Expression and Purification Revenue by Application (2027-2032) & (US$ Million) Table 188. Europe Recombinant Protein Expression and Purification Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Europe Recombinant Protein Expression and Purification Revenue by Country (2021-2026) & (US$ Million) Table 190. Europe Recombinant Protein Expression and Purification Revenue by Country (US$ Million) & (2027-2032) Table 191. China Recombinant Protein Expression and Purification Revenue by Type (2021-2026) & (US$ Million) Table 192. China Recombinant Protein Expression and Purification Revenue by Type (2027-2032) & (US$ Million) Table 193. China Recombinant Protein Expression and Purification Revenue by Application (2021-2026) & (US$ Million) Table 194. China Recombinant Protein Expression and Purification Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Recombinant Protein Expression and Purification Revenue by Type (2021-2026) & (US$ Million) Table 196. Asia Recombinant Protein Expression and Purification Revenue by Type (2027-2032) & (US$ Million) Table 197. Asia Recombinant Protein Expression and Purification Revenue by Application (2021-2026) & (US$ Million) Table 198. Asia Recombinant Protein Expression and Purification Revenue by Application (2027-2032) & (US$ Million) Table 199. Asia Recombinant Protein Expression and Purification Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Recombinant Protein Expression and Purification Revenue by Region (US$ Million) & (2021-2026) Table 201. Asia Recombinant Protein Expression and Purification Revenue by Region (US$ Million) & (2027-2032) Table 202. SAMEA Recombinant Protein Expression and Purification Revenue by Type (2021-2026) & (US$ Million) Table 203. SAMEA Recombinant Protein Expression and Purification Revenue by Type (2027-2032) & (US$ Million) Table 204. SAMEA Recombinant Protein Expression and Purification Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Recombinant Protein Expression and Purification Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Recombinant Protein Expression and Purification Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Recombinant Protein Expression and Purification Revenue by Country (2021-2026) & (US$ Million) Table 208. SAMEA Recombinant Protein Expression and Purification Revenue by Country (US$ Million) & (2027-2032) Table 209. Research Programs/Design for This Report Table 210. Authors List of This Report Table 211. Secondary Sources Table 212. Primary Sources List of Figures Figure 1. Recombinant Protein Expression and Purification Image Figure 2. Global Recombinant Protein Expression and Purification Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Protein Expression and Purification Market Size Share 2021 VS 2025 VS 2032 Figure 4. Microbial Expression Image Figure 5. Mammalian Cell Expression Image Figure 6. Others Image Figure 7. Global Recombinant Protein Expression and Purification Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Recombinant Protein Expression and Purification Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical and Biopharmaceutical Company Image Figure 10. Research Laboratory Image Figure 11. Hospital Image Figure 12. Other Image Figure 13. Global Recombinant Protein Expression and Purification Market Size (US$ Million) & (2021-2032) Figure 14. Global Recombinant Protein Expression and Purification Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Recombinant Protein Expression and Purification Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Recombinant Protein Expression and Purification Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Recombinant Protein Expression and Purification Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Recombinant Protein Expression and Purification Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Recombinant Protein Expression and Purification Revenue Market Share by Type (2021-2032) Figure 21. Global Recombinant Protein Expression and Purification Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Recombinant Protein Expression and Purification Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Recombinant Protein Expression and Purification Revenue Market Share by Application (2021-2032) Figure 24. North America Recombinant Protein Expression and Purification Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Recombinant Protein Expression and Purification Revenue Share by Type (2021-2032) Figure 26. North America Recombinant Protein Expression and Purification Revenue Share by Application (2021-2032) Figure 27. North America Recombinant Protein Expression and Purification Revenue Share by Country (2021-2032) Figure 28. United States Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Recombinant Protein Expression and Purification Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Recombinant Protein Expression and Purification Revenue Share by Type (2021-2032) Figure 33. Europe Recombinant Protein Expression and Purification Revenue Share by Application (2021-2032) Figure 34. Europe Recombinant Protein Expression and Purification Revenue Share by Country (2021-2032) Figure 35. Germany Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Recombinant Protein Expression and Purification Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Recombinant Protein Expression and Purification Revenue Share by Type (2021-2032) Figure 45. China Recombinant Protein Expression and Purification Revenue Share by Application (2021-2032) Figure 46. Asia Recombinant Protein Expression and Purification Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Recombinant Protein Expression and Purification Revenue Share by Type (2021-2032) Figure 48. Asia Recombinant Protein Expression and Purification Revenue Share by Application (2021-2032) Figure 49. Asia Recombinant Protein Expression and Purification Revenue Share by Region (2021-2032) Figure 50. Japan Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Recombinant Protein Expression and Purification Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Recombinant Protein Expression and Purification Revenue Share by Type (2021-2032) Figure 58. SAMEA Recombinant Protein Expression and Purification Revenue Share by Application (2021-2032) Figure 59. SAMEA Recombinant Protein Expression and Purification Revenue Share by Country (2021-2032) Figure 60. Brazil Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Recombinant Protein Expression and Purification Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Microbial Expression
  • Mammalian Cell Expression
  • Others
Applications
  • Pharmaceutical and Biopharmaceutical Company
  • Research Laboratory
  • Hospital
  • Other
Companies covered
  • Charles River
  • Biomatik
  • R&D Systems
  • Applied Biological Materials Inc. (abm)
  • VectorBuilder
  • BiologicsCorp
  • Proteos
  • RayBiotech
  • Leinco Technologies
  • Kinexus Bioinformatics
  • InVivo BioTech Services GmbH
  • Expression Systems
  • Creative Biolabs
  • G&P Biosciences
  • Eurofins Discovery
  • Levprot Bioscience
  • eEnzyme
  • NorthX Biologics
  • Jubilant Biosys
  • GenScript
  • Boster Bio
  • Sino Biological
  • WuXi Biologic
  • CUSABIO TECHNOLOGY
  • OriGene Technologies
  • ProMab Biotechnologies
  • Creative BioMart
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Protein Expression and Purification Market by Type
  3. 1.2.1 Global Recombinant Protein Expression and Purification Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Microbial Expression
  5. 1.2.3 Mammalian Cell Expression
  6. 1.2.4 Others
  7. 1.3 Recombinant Protein Expression and Purification Market by Application
  8. 1.3.1 Global Recombinant Protein Expression and Purification Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical and Biopharmaceutical Company
  10. 1.3.3 Research Laboratory
  11. 1.3.4 Hospital
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Recombinant Protein Expression and Purification Market Dynamics
  1. 2.1 Recombinant Protein Expression and Purification Industry Trends
  2. 2.2 Recombinant Protein Expression and Purification Industry Drivers
  3. 2.3 Recombinant Protein Expression and Purification Industry Opportunities and Challenges
  4. 2.4 Recombinant Protein Expression and Purification Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Recombinant Protein Expression and Purification Market Perspective (2021-2032)
  2. 3.2 Global Recombinant Protein Expression and Purification Growth Trends by Region
  3. 3.2.1 Global Recombinant Protein Expression and Purification Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Protein Expression and Purification Market Size by Region (2021-2026)
  5. 3.2.3 Global Recombinant Protein Expression and Purification Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Recombinant Protein Expression and Purification Revenue by Players
  2. 4.1.1 Global Recombinant Protein Expression and Purification Revenue by Players (2021-2026)
  3. 4.1.2 Global Recombinant Protein Expression and Purification Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Recombinant Protein Expression and Purification Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Protein Expression and Purification Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Recombinant Protein Expression and Purification Key Players Headquarters & Area Served
  7. 4.4 Global Recombinant Protein Expression and Purification Players, Product Type & Application
  8. 4.5 Global Recombinant Protein Expression and Purification Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Recombinant Protein Expression and Purification Market CR5 and HHI
  11. 4.6.3 2025 Recombinant Protein Expression and Purification Tier 1, Tier 2, and Tier 3
5 Recombinant Protein Expression and Purification Market Size by Type
  1. 5.1 Global Recombinant Protein Expression and Purification Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Recombinant Protein Expression and Purification Revenue by Type (2021-2032)
  3. 5.3 Global Recombinant Protein Expression and Purification Revenue Market Share by Type (2021-2032)
6 Recombinant Protein Expression and Purification Market Size by Application
  1. 6.1 Global Recombinant Protein Expression and Purification Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Recombinant Protein Expression and Purification Revenue by Application (2021-2032)
  3. 6.3 Global Recombinant Protein Expression and Purification Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Charles River
  2. 7.1.1 Charles River Company Information
  3. 7.1.2 Charles River Business Overview
  4. 7.1.3 Charles River Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Charles River Recombinant Protein Expression and Purification Product Portfolio
  6. 7.1.5 Charles River Recent Developments
  7. 7.2 Biomatik
  8. 7.2.1 Biomatik Company Information
  9. 7.2.2 Biomatik Business Overview
  10. 7.2.3 Biomatik Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biomatik Recombinant Protein Expression and Purification Product Portfolio
  12. 7.2.5 Biomatik Recent Developments
  13. 7.3 R&D Systems
  14. 7.3.1 R&D Systems Company Information
  15. 7.3.2 R&D Systems Business Overview
  16. 7.3.3 R&D Systems Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  17. 7.3.4 R&D Systems Recombinant Protein Expression and Purification Product Portfolio
  18. 7.3.5 R&D Systems Recent Developments
  19. 7.4 Applied Biological Materials Inc. (abm)
  20. 7.4.1 Applied Biological Materials Inc. (abm) Company Information
  21. 7.4.2 Applied Biological Materials Inc. (abm) Business Overview
  22. 7.4.3 Applied Biological Materials Inc. (abm) Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Applied Biological Materials Inc. (abm) Recombinant Protein Expression and Purification Product Portfolio
  24. 7.4.5 Applied Biological Materials Inc. (abm) Recent Developments
  25. 7.5 VectorBuilder
  26. 7.5.1 VectorBuilder Company Information
  27. 7.5.2 VectorBuilder Business Overview
  28. 7.5.3 VectorBuilder Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  29. 7.5.4 VectorBuilder Recombinant Protein Expression and Purification Product Portfolio
  30. 7.5.5 VectorBuilder Recent Developments
  31. 7.6 BiologicsCorp
  32. 7.6.1 BiologicsCorp Company Information
  33. 7.6.2 BiologicsCorp Business Overview
  34. 7.6.3 BiologicsCorp Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  35. 7.6.4 BiologicsCorp Recombinant Protein Expression and Purification Product Portfolio
  36. 7.6.5 BiologicsCorp Recent Developments
  37. 7.7 Proteos
  38. 7.7.1 Proteos Company Information
  39. 7.7.2 Proteos Business Overview
  40. 7.7.3 Proteos Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Proteos Recombinant Protein Expression and Purification Product Portfolio
  42. 7.7.5 Proteos Recent Developments
  43. 7.8 RayBiotech
  44. 7.8.1 RayBiotech Company Information
  45. 7.8.2 RayBiotech Business Overview
  46. 7.8.3 RayBiotech Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  47. 7.8.4 RayBiotech Recombinant Protein Expression and Purification Product Portfolio
  48. 7.8.5 RayBiotech Recent Developments
  49. 7.9 Leinco Technologies
  50. 7.9.1 Leinco Technologies Company Information
  51. 7.9.2 Leinco Technologies Business Overview
  52. 7.9.3 Leinco Technologies Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Leinco Technologies Recombinant Protein Expression and Purification Product Portfolio
  54. 7.9.5 Leinco Technologies Recent Developments
  55. 7.10 Kinexus Bioinformatics
  56. 7.10.1 Kinexus Bioinformatics Company Information
  57. 7.10.2 Kinexus Bioinformatics Business Overview
  58. 7.10.3 Kinexus Bioinformatics Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Kinexus Bioinformatics Recombinant Protein Expression and Purification Product Portfolio
  60. 7.10.5 Kinexus Bioinformatics Recent Developments
  61. 7.11 InVivo BioTech Services GmbH
  62. 7.11.1 InVivo BioTech Services GmbH Company Information
  63. 7.11.2 InVivo BioTech Services GmbH Business Overview
  64. 7.11.3 InVivo BioTech Services GmbH Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  65. 7.11.4 InVivo BioTech Services GmbH Recombinant Protein Expression and Purification Product Portfolio
  66. 7.11.5 InVivo BioTech Services GmbH Recent Developments
  67. 7.12 Expression Systems
  68. 7.12.1 Expression Systems Company Information
  69. 7.12.2 Expression Systems Business Overview
  70. 7.12.3 Expression Systems Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Expression Systems Recombinant Protein Expression and Purification Product Portfolio
  72. 7.12.5 Expression Systems Recent Developments
  73. 7.13 Creative Biolabs
  74. 7.13.1 Creative Biolabs Company Information
  75. 7.13.2 Creative Biolabs Business Overview
  76. 7.13.3 Creative Biolabs Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Creative Biolabs Recombinant Protein Expression and Purification Product Portfolio
  78. 7.13.5 Creative Biolabs Recent Developments
  79. 7.14 G&P Biosciences
  80. 7.14.1 G&P Biosciences Company Information
  81. 7.14.2 G&P Biosciences Business Overview
  82. 7.14.3 G&P Biosciences Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  83. 7.14.4 G&P Biosciences Recombinant Protein Expression and Purification Product Portfolio
  84. 7.14.5 G&P Biosciences Recent Developments
  85. 7.15 Eurofins Discovery
  86. 7.15.1 Eurofins Discovery Company Information
  87. 7.15.2 Eurofins Discovery Business Overview
  88. 7.15.3 Eurofins Discovery Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Eurofins Discovery Recombinant Protein Expression and Purification Product Portfolio
  90. 7.15.5 Eurofins Discovery Recent Developments
  91. 7.16 Levprot Bioscience
  92. 7.16.1 Levprot Bioscience Company Information
  93. 7.16.2 Levprot Bioscience Business Overview
  94. 7.16.3 Levprot Bioscience Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Levprot Bioscience Recombinant Protein Expression and Purification Product Portfolio
  96. 7.16.5 Levprot Bioscience Recent Developments
  97. 7.17 eEnzyme
  98. 7.17.1 eEnzyme Company Information
  99. 7.17.2 eEnzyme Business Overview
  100. 7.17.3 eEnzyme Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  101. 7.17.4 eEnzyme Recombinant Protein Expression and Purification Product Portfolio
  102. 7.17.5 eEnzyme Recent Developments
  103. 7.18 NorthX Biologics
  104. 7.18.1 NorthX Biologics Company Information
  105. 7.18.2 NorthX Biologics Business Overview
  106. 7.18.3 NorthX Biologics Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  107. 7.18.4 NorthX Biologics Recombinant Protein Expression and Purification Product Portfolio
  108. 7.18.5 NorthX Biologics Recent Developments
  109. 7.19 Jubilant Biosys
  110. 7.19.1 Jubilant Biosys Company Information
  111. 7.19.2 Jubilant Biosys Business Overview
  112. 7.19.3 Jubilant Biosys Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Jubilant Biosys Recombinant Protein Expression and Purification Product Portfolio
  114. 7.19.5 Jubilant Biosys Recent Developments
  115. 7.20 GenScript
  116. 7.20.1 GenScript Company Information
  117. 7.20.2 GenScript Business Overview
  118. 7.20.3 GenScript Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  119. 7.20.4 GenScript Recombinant Protein Expression and Purification Product Portfolio
  120. 7.20.5 GenScript Recent Developments
  121. 7.21 Boster Bio
  122. 7.21.1 Boster Bio Company Information
  123. 7.21.2 Boster Bio Business Overview
  124. 7.21.3 Boster Bio Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Boster Bio Recombinant Protein Expression and Purification Product Portfolio
  126. 7.21.5 Boster Bio Recent Developments
  127. 7.22 Sino Biological
  128. 7.22.1 Sino Biological Company Information
  129. 7.22.2 Sino Biological Business Overview
  130. 7.22.3 Sino Biological Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Sino Biological Recombinant Protein Expression and Purification Product Portfolio
  132. 7.22.5 Sino Biological Recent Developments
  133. 7.23 WuXi Biologic
  134. 7.23.1 WuXi Biologic Company Information
  135. 7.23.2 WuXi Biologic Business Overview
  136. 7.23.3 WuXi Biologic Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  137. 7.23.4 WuXi Biologic Recombinant Protein Expression and Purification Product Portfolio
  138. 7.23.5 WuXi Biologic Recent Developments
  139. 7.24 CUSABIO TECHNOLOGY
  140. 7.24.1 CUSABIO TECHNOLOGY Company Information
  141. 7.24.2 CUSABIO TECHNOLOGY Business Overview
  142. 7.24.3 CUSABIO TECHNOLOGY Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  143. 7.24.4 CUSABIO TECHNOLOGY Recombinant Protein Expression and Purification Product Portfolio
  144. 7.24.5 CUSABIO TECHNOLOGY Recent Developments
  145. 7.25 OriGene Technologies
  146. 7.25.1 OriGene Technologies Company Information
  147. 7.25.2 OriGene Technologies Business Overview
  148. 7.25.3 OriGene Technologies Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  149. 7.25.4 OriGene Technologies Recombinant Protein Expression and Purification Product Portfolio
  150. 7.25.5 OriGene Technologies Recent Developments
  151. 7.26 ProMab Biotechnologies
  152. 7.26.1 ProMab Biotechnologies Company Information
  153. 7.26.2 ProMab Biotechnologies Business Overview
  154. 7.26.3 ProMab Biotechnologies Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  155. 7.26.4 ProMab Biotechnologies Recombinant Protein Expression and Purification Product Portfolio
  156. 7.26.5 ProMab Biotechnologies Recent Developments
  157. 7.27 Creative BioMart
  158. 7.27.1 Creative BioMart Company Information
  159. 7.27.2 Creative BioMart Business Overview
  160. 7.27.3 Creative BioMart Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Creative BioMart Recombinant Protein Expression and Purification Product Portfolio
  162. 7.27.5 Creative BioMart Recent Developments
  163. 7.28 Thermo Fisher Scientific
  164. 7.28.1 Thermo Fisher Scientific Company Information
  165. 7.28.2 Thermo Fisher Scientific Business Overview
  166. 7.28.3 Thermo Fisher Scientific Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Thermo Fisher Scientific Recombinant Protein Expression and Purification Product Portfolio
  168. 7.28.5 Thermo Fisher Scientific Recent Developments
8 North America
  1. 8.1 North America Recombinant Protein Expression and Purification Revenue (2021-2032)
  2. 8.2 North America Recombinant Protein Expression and Purification Revenue by Type (2021-2032)
  3. 8.2.1 North America Recombinant Protein Expression and Purification Revenue by Type (2021-2026)
  4. 8.2.2 North America Recombinant Protein Expression and Purification Revenue by Type (2027-2032)
  5. 8.3 North America Recombinant Protein Expression and Purification Revenue Share by Type (2021-2032)
  6. 8.4 North America Recombinant Protein Expression and Purification Revenue by Application (2021-2032)
  7. 8.4.1 North America Recombinant Protein Expression and Purification Revenue by Application (2021-2026)
  8. 8.4.2 North America Recombinant Protein Expression and Purification Revenue by Application (2027-2032)
  9. 8.5 North America Recombinant Protein Expression and Purification Revenue Share by Application (2021-2032)
  10. 8.6 North America Recombinant Protein Expression and Purification Revenue by Country
  11. 8.6.1 North America Recombinant Protein Expression and Purification Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Recombinant Protein Expression and Purification Revenue by Country (2021-2026)
  13. 8.6.3 North America Recombinant Protein Expression and Purification Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Recombinant Protein Expression and Purification Revenue (2021-2032)
  2. 9.2 Europe Recombinant Protein Expression and Purification Revenue by Type (2021-2032)
  3. 9.2.1 Europe Recombinant Protein Expression and Purification Revenue by Type (2021-2026)
  4. 9.2.2 Europe Recombinant Protein Expression and Purification Revenue by Type (2027-2032)
  5. 9.3 Europe Recombinant Protein Expression and Purification Revenue Share by Type (2021-2032)
  6. 9.4 Europe Recombinant Protein Expression and Purification Revenue by Application (2021-2032)
  7. 9.4.1 Europe Recombinant Protein Expression and Purification Revenue by Application (2021-2026)
  8. 9.4.2 Europe Recombinant Protein Expression and Purification Revenue by Application (2027-2032)
  9. 9.5 Europe Recombinant Protein Expression and Purification Revenue Share by Application (2021-2032)
  10. 9.6 Europe Recombinant Protein Expression and Purification Revenue by Country
  11. 9.6.1 Europe Recombinant Protein Expression and Purification Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Recombinant Protein Expression and Purification Revenue by Country (2021-2026)
  13. 9.6.3 Europe Recombinant Protein Expression and Purification Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Recombinant Protein Expression and Purification Revenue (2021-2032)
  2. 10.2 China Recombinant Protein Expression and Purification Revenue by Type (2021-2032)
  3. 10.2.1 China Recombinant Protein Expression and Purification Revenue by Type (2021-2026)
  4. 10.2.2 China Recombinant Protein Expression and Purification Revenue by Type (2027-2032)
  5. 10.3 China Recombinant Protein Expression and Purification Revenue Share by Type (2021-2032)
  6. 10.4 China Recombinant Protein Expression and Purification Revenue by Application (2021-2032)
  7. 10.4.1 China Recombinant Protein Expression and Purification Revenue by Application (2021-2026)
  8. 10.4.2 China Recombinant Protein Expression and Purification Revenue by Application (2027-2032)
  9. 10.5 China Recombinant Protein Expression and Purification Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Protein Expression and Purification Revenue (2021-2032)
  2. 11.2 Asia Recombinant Protein Expression and Purification Revenue by Type (2021-2032)
  3. 11.2.1 Asia Recombinant Protein Expression and Purification Revenue by Type (2021-2026)
  4. 11.2.2 Asia Recombinant Protein Expression and Purification Revenue by Type (2027-2032)
  5. 11.3 Asia Recombinant Protein Expression and Purification Revenue Share by Type (2021-2032)
  6. 11.4 Asia Recombinant Protein Expression and Purification Revenue by Application (2021-2032)
  7. 11.4.1 Asia Recombinant Protein Expression and Purification Revenue by Application (2021-2026)
  8. 11.4.2 Asia Recombinant Protein Expression and Purification Revenue by Application (2027-2032)
  9. 11.5 Asia Recombinant Protein Expression and Purification Revenue Share by Application (2021-2032)
  10. 11.6 Asia Recombinant Protein Expression and Purification Revenue by Country
  11. 11.6.1 Asia Recombinant Protein Expression and Purification Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Recombinant Protein Expression and Purification Revenue by Country (2021-2026)
  13. 11.6.3 Asia Recombinant Protein Expression and Purification Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Protein Expression and Purification Revenue (2021-2032)
  2. 12.2 SAMEA Recombinant Protein Expression and Purification Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Recombinant Protein Expression and Purification Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Recombinant Protein Expression and Purification Revenue by Type (2027-2032)
  5. 12.3 SAMEA Recombinant Protein Expression and Purification Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Recombinant Protein Expression and Purification Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Recombinant Protein Expression and Purification Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Recombinant Protein Expression and Purification Revenue by Application (2027-2032)
  9. 12.5 SAMEA Recombinant Protein Expression and Purification Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Recombinant Protein Expression and Purification Revenue by Country
  11. 12.6.1 SAMEA Recombinant Protein Expression and Purification Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Recombinant Protein Expression and Purification Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Recombinant Protein Expression and Purification Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst